跳至主要内容
临床试验/CTRI/2017/11/010717
CTRI/2017/11/010717进行中(未招募)2 期

Effect Of Sankarasweda With Kolakulatthadi Churna Heated In Dhanyamla In Rheumatoid Arthritis Wrt Pain and Stiffness Of Joints

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 29 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either sex with age between 30 and 60 years
  • 2.Presence of any four out of the following seven criteria (according to 1987, revised criteria of American College of Rheumatology)
  • a.Morning stiffness
  • b.Arthritis of three or more joints, at least three joint areas, observed by
  • c.Physician, having pain with soft tissue swelling or joint effusion, not just bonyover growth.
  • d.Arthritis of hand joints, at least 1 area in wrist and hand is swollen.
  • e.Symmetric arthritis (more than 6 week duration).
  • f.Presence of Rheumatoid Nodules
  • g.Serum Rheumatoid factor- positive
  • h.Typical radiographic changes of arthritis on PA view of hand & wrist radiograph that must include erosions or unequivocal bony decalcification,localized in or adjacent to involved joints.
  • 3.Willing to participate in the study and to give written informed consent.

排除标准

  • 1.Patients who have developed complications of Rheumatoid Arthritis e.g.deformity of joints / bones, pleura-pericardial disease, or else.
  • 2.Patients who are unable to walk without support and / or confined to wheel chair.
  • 3.Patients with structural deformity as the complication of RA.
  • 4.Duration more than 10 years
  • 5.Patients with poorly controlled Hypertension( >= 160/100 mmHg)
  • 6.Patients suffering with Diabetes Mellitus (Blood Sugar Fasting > 126 mg/dl).
  • 7.Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis etc.
  • 8.Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants,anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study.
  • 9.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome,Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
  • 10.Symptomatic patients with clinical evidence of Heart failure.
  • 11.Patients with concurrent serious hepatic disorder (defined as Aspartate AminoTransferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin,Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction(Uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease[COPD]), or any other condition that may jeopardize the study.
  • 12.Alcoholics and/or drug abusers.
  • 13.H/o hypersensitivity to any of the trial drugs or their ingredients.
  • 14.Pregnant / lactating woman.
  • 15.Patients who have completed participation in any other clinical trial during the past six months.
  • 16.Any other condition which the Investigator thinks may jeopardize the study.

研究者

相似试验